← Leaderboards
Spencer A Knapp
Rutgers The St Univ Of Nj New Brunswick
$1,653,818
Attributed
$6,398,743
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–15$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,398,743 · 3
By mechanism
R01$5,931,156 · 1
R21$466,500 · 1
P41$1,087 · 1
Top collaborators
- R Kiplin Guy5 shared
- Dennis E Kyle5 shared
- Roman Manetsch5 shared
- Jeremy Nicholas Burrows2 shared
- David Waterson2 shared
- James Duffy1 shared
Most similar at Rutgers The St Univ Of Nj New Brunswick
Same institution · by research overlap
- Richard H. Ebright$32,377,168
- Wilma K Olson$7,244,162
- Charles M. Roth$3,362,417
- Longqin Hu$3,572,091
Others in their field
Top investigators on “Meetings”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$566,636,343
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$296,614,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$204,659,093
- Peter B. Gilbert · Fred Hutchinson Cancer Center$167,167,617
Research focus
MeetingsMorbidity - Disease RateInfectionMalariaMetabolismBaseFundingHigh Throughput ScreeningGrowthLeadApplications GrantsHospitalsChildChloroquineAntimalarialsDrug CandidateCandidate SelectionDrug DevelopmentDrug ResistanceAdsorptionInhibitor/AntagonistErythrocytesExcretory FunctionPharmaceutical Preparations
Grant awards (8)
Validation of New Antimalarial Leads$1,190,932
R01 · FY2015 · AI
Validation of New Antimalarial Leads$1,190,932
R01 · FY2014 · AI
Validation of New Antimalarial Leads$1,119,476
R01 · FY2013 · AI
Validation of New Antimalarial Leads$1,190,932
R01 · FY2012 · AI
Validation of New Antimalarial Leads$1,238,884
R01 · FY2011 · AI
Inhibition of Tubercular Mycothiol Pathways$233,250
R21 · FY2004 · AI
NEW METHODS OF CARBON CARBON BOND FORMATION$1,087
P41 · FY2004 · RR
Inhibition of Tubercular Mycothiol Pathways$233,250
R21 · FY2003 · AI